AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty
AnaptysBio shares tumble after legal fight with GSK over cancer drug license
GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties
GSK, AnaptysBio Sue Each Other Over Cancer Drug License